Pill Truvada Can Help Prevent AIDS Among Gay And Bisexual Men

Gay and bisexual men have disproportionately infected with HIV and now there is a pill that can resolve this issue. According to a new study, the rate of new HIV infections among gay and bisexual men can drop by a this for the next ten years if eligible men will be given the drug. 

According to the new research, this drug can protect men from the said virus. The US Centers for Disase Control and Prevntion claimed that gay and bisexual men will be given the drug if they met one of the three criteria, Fox News reports. 

First, they must have had unprotected anal sex in a monogamous relationship with someone who has not been tested for HIV. Second, they have unprotected anal sex with a partner not within a monogamous relationship.  Lastly, they have engaged in anal sex with someone who has already tested positive for HIV. 

The so-called drug is the Truvada, which is manuacturered by Gilead. According to the new research, if 40% of gay and bisexual men considered high risk for the infection would have access to this treatment, around 1,162 infections among 100,000 gay and bisexual in over the next decade could avoid being infected. The findings are now published in The Journal of Infectious Diseases.

Truvada is said to be comprised of two antiretroviral drugs combined. Both of these drugs can work to keep the human immunodeficiency virus at bay. It is widely known that this infection is the one causing AIDS.  With this drug, the HIV will be stopped from reproducing in the body. The drug is also approved by the US Food and Drug Administration already. 

"We were all interested in estimating the public health impact and efficiency of PrEP," said Samuel Jenness, the study's lead author from Emory University in Atlanta.

According to Jenness, the unfortunate reality is that only 5 to 10 percent of gay and bisexual men now have access to the drug. There is a need to counsel men about the appropriate method of taking the drug and adhering to it everyday.